Progress of Circulating Tumor Cells in Cancer Management-Reference-Cited by-同舟云学术

Progress of Circulating Tumor Cells in Cancer Management

Published:2015-05-06 Issue:3 Volume:15 Page:509-516
ISSN:1533-0346
Container-title:Technology in Cancer Research & Treatment
language:en
Short-container-title:Technol Cancer Res Treat

Author:

Zhang Chufeng¹²,Wang Lijie¹²,Guan Yan²,Sun Yulan²,Liu Xiuju²,Zhu Dongyuan²,Guo Qisen²

Affiliation:

1. School of Medicine and Life Sciences, University of Jinan-Shandong, Academy of Medical Sciences, Jinan, China

2. Academy of Medical Sciences, Shandong Cancer Hospital, Jinan, Shandong, China

Abstract

Circulating tumor cells are low-frequency cells that are shed into the peripheral bloodstream from a primary solid tumor and/or metastasis. Although these cells were recognized initially in 1869, it is only in the past 2 decades that they have been isolated for use as a surrogate biomarker to monitor response to therapy, evaluate prognosis, detect tumor mutations, assist in selecting personalized medicine, and enable earlier cancer diagnosis.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1533034615583762

Reference70 articles.

1. Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer

2. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility

3. Tumor heterogeneity in the clinic: is it a real problem?

4. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

5. Circulating Epithelial Cells in Patients with Benign Colon Diseases

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid biopsy in thyroid cancer: from circulating biomarkers to a new prospective of tumor monitoring and therapy;Minerva Endocrinology;2021-03

2. Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma;Oncology Reports;2020-03-09

3. Modelling responses to spatially fractionated radiation fields using preclinical image-guided radiotherapy;The British Journal of Radiology;2017-01